Low Evidence Research Overview

Epithalon Research for Anti-Aging

An evidence-based overview of research examining Epithalon in the context of anti-aging. This page synthesizes findings from peer-reviewed literature.

Research Summary

Epithalon is marketed primarily for anti-aging based on claimed telomerase activation and lifespan extension in animal models. Russian research reports prolonged lifespan in mice and fruit flies and extended cellular replicative capacity via telomerase activation and telomere elongation in human fetal fibroblasts. A 2025 independent UK study confirmed telomerase activation in human cells in vitro. No controlled human clinical trials have evaluated anti-aging outcomes.

Referenced Studies

Click any PMID to view the full study on PubMed.

Important Disclaimer

This page summarizes research findings and does not constitute medical advice. Epithalon has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.